Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Nature Immunology
|
August 6, 2013
Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cells
Angelo Castello, Mauro Gaya, Johannes Tucholski, et al.
Cancers
|
October 27, 2022
The Role of [<sup>68</sup>Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review
Matteo Caracciolo, Angelo Castello, Luca Urso, et al.
Nuclear Medicine Communications
|
August 21, 2018
Role of 11C-choline PET/CT in radiation therapy planning of patients with prostate cancer
Giuseppe R D'Agostino, Egesta Lopci, Lucia Di Brina, et al.
Biomolecules
|
January 25, 2025
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
Ilham Badrane, Angelo Castello, Matteo Brunelli, et al.
Endocrine
|
August 26, 2022
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review
Luca Urso, Alberto Nieri, Ilaria Rambaldi, et al.
Diagnostics (Basel, Switzerland)
|
February 25, 2023
Relevance of Volumetric Parameters Applied to [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
Luca Urso, Angelo Castello, Giorgio Treglia, et al.
Molecular Diagnosis & Therapy
|
January 8, 2025
The Role of [<sup>18</sup>F]F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic Lesions
Daniele Antonio Pizzuto, Angelo Castello, Marco Chiappetta, et al.
Journal of Cancer Research and Clinical Oncology
|
February 26, 2022
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives
Luca Urso, Angelo Castello, Giovanni Christian Rocca, et al.
Journal of Clinical Medicine
|
May 11, 2024
Does FDG PET-Based Radiomics Have an Added Value for Prediction of Overall Survival in Non-Small Cell Lung Cancer?
Andrea Ciarmiello, Elisabetta Giovannini, Francesca Tutino, et al.
Cancer Immunology, Immunotherapy : CII
|
September 5, 2019
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer
Fabio Grizzi, Angelo Castello, Dorina Qehajaj, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Nature Immunology
|
August 6, 2013
Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cells
Angelo Castello, Mauro Gaya, Johannes Tucholski, et al.
Cancers
|
October 27, 2022
The Role of [<sup>68</sup>Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review
Matteo Caracciolo, Angelo Castello, Luca Urso, et al.
Nuclear Medicine Communications
|
August 21, 2018
Role of 11C-choline PET/CT in radiation therapy planning of patients with prostate cancer
Giuseppe R D'Agostino, Egesta Lopci, Lucia Di Brina, et al.
Biomolecules
|
January 25, 2025
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
Ilham Badrane, Angelo Castello, Matteo Brunelli, et al.
Endocrine
|
August 26, 2022
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review
Luca Urso, Alberto Nieri, Ilaria Rambaldi, et al.
Diagnostics (Basel, Switzerland)
|
February 25, 2023
Relevance of Volumetric Parameters Applied to [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
Luca Urso, Angelo Castello, Giorgio Treglia, et al.
Molecular Diagnosis & Therapy
|
January 8, 2025
The Role of [<sup>18</sup>F]F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic Lesions
Daniele Antonio Pizzuto, Angelo Castello, Marco Chiappetta, et al.
Journal of Cancer Research and Clinical Oncology
|
February 26, 2022
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives
Luca Urso, Angelo Castello, Giovanni Christian Rocca, et al.
Journal of Clinical Medicine
|
May 11, 2024
Does FDG PET-Based Radiomics Have an Added Value for Prediction of Overall Survival in Non-Small Cell Lung Cancer?
Andrea Ciarmiello, Elisabetta Giovannini, Francesca Tutino, et al.
Cancer Immunology, Immunotherapy : CII
|
September 5, 2019
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer
Fabio Grizzi, Angelo Castello, Dorina Qehajaj, et al.
Page
of 8